complex roles of noncoding rnas in colorectal cancer resistance to anti-egfr therapy
Published 1 year ago • 147 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:33
acquired resistance to anti-egfr therapy in colorectal cancer
-
16:56
colorectal cancer with acquired resistance to egfr antibodies: how to manage?
-
1:31
the role of trna-derived noncoding rnas in digestive system disease
-
2:01
clarifying the mechanism of egfr inhibition in kras g13d colorectal cancer
-
2:53
the emerging role of mrd in colorectal cancer decision making
-
6:36
detecting resistance to egfr rechallenge in ras/raf wt crc
-
2:10
anti-egfr therapy for ras wild-type left-sided colorectal cancer
-
2:14
anti-egfr rechallenge therapy with or without trametinib in addition to panitumumab in advanced crc
-
4:52
the role of biomarkers in colorectal cancer
-
29:45
keynote lecture 4: the braf pathway in crc?
-
3:23
colorectal cancer and the role of angiogenesis in cancer development
-
31:17
molecular testing and the role of her2 in managing advanced colorectal cancer
-
1:50
the emerging role of genetic testing in colorectal cancer
-
0:11
life of young colon cancer survivor
-
47:45
resistance in braf and kras mutant cancers - by ryan corcoran, md, phd
-
22:10
novel agents and targets in colorectal cancer
-
17:17
debate: targeted therapy for ras/braf wt left sided colon cancers - egfr antibodies are mandatory
-
22:41
surgical principles in colorectal cancer - dr david rosen
-
5:30
treatment options for advanced colorectal cancer